Angelini Melissa Andreia Silva - 18 Mar 2026 Form 3 Insider Report for Sofgen Pharma S.A.

Role
Interim CEO
Signature
/s/ Freddy Andres Lozano Reyes, attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 15:22:17 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Silva Angelini Melissa Andreia Interim CEO 11600 MIRAMAR PARKWAY, SUITE 300, MIRAMAR /s/ Freddy Andres Lozano Reyes, attorney-in-fact 18 Mar 2026 0002121077

No securities are beneficially owned.

Remarks:

See Exhibit 24 - Power of Attorney.